280 related articles for article (PubMed ID: 25121977)
1. Cost-utility analysis of a treatment advice to discontinue inappropriate long-term antidepressant use in primary care.
Eveleigh R; Grutters J; Muskens E; Oude Voshaar R; van Weel C; Speckens A; Lucassen P
Fam Pract; 2014 Oct; 31(5):578-84. PubMed ID: 25121977
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan.
Sado M; Knapp M; Yamauchi K; Fujisawa D; So M; Nakagawa A; Kikuchi T; Ono Y
Aust N Z J Psychiatry; 2009 Jun; 43(6):539-47. PubMed ID: 19440886
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of involving nurse specialists for adult patients with urinary incontinence in primary care compared to care-as-usual: an economic evaluation alongside a pragmatic randomized controlled trial.
Albers-Heitner CP; Joore MA; Winkens RA; Lagro-Janssen AL; Severens JL; Berghmans LC
Neurourol Urodyn; 2012 Apr; 31(4):526-34. PubMed ID: 22275126
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of a minimal intervention for stress-related sick leave in general practice: results of an economic evaluation alongside a pragmatic randomised control trial.
Uegaki K; Bakker I; de Bruijne M; van der Beek A; Terluin B; van Marwijk H; Heymans M; Stalman W; van Mechelen W
J Affect Disord; 2010 Jan; 120(1-3):177-87. PubMed ID: 19439362
[TBL] [Abstract][Full Text] [Related]
7. Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.
Revicki DA; Simon GE; Chan K; Katon W; Heiligenstein J
J Fam Pract; 1998 Dec; 47(6):446-52. PubMed ID: 9866670
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
[TBL] [Abstract][Full Text] [Related]
9. REDUCING POTENTIALLY INAPPROPRIATE PRESCRIBING FOR OLDER PEOPLE IN PRIMARY CARE: COST-EFFECTIVENESS OF THE OPTI-SCRIPT INTERVENTION.
Gillespie P; Clyne B; Raymakers A; Fahey T; Hughes CM; Smith SM
Int J Technol Assess Health Care; 2017 Jan; 33(4):494-503. PubMed ID: 29019297
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of integrated care for elderly depressed patients in the PRISM-E study.
Wiley-Exley E; Domino ME; Maxwell J; Levkoff SE
J Ment Health Policy Econ; 2009 Dec; 12(4):205-13. PubMed ID: 20195008
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.
Pyne JM; Fortney JC; Tripathi SP; Maciejewski ML; Edlund MJ; Williams DK
Arch Gen Psychiatry; 2010 Aug; 67(8):812-21. PubMed ID: 20679589
[TBL] [Abstract][Full Text] [Related]
12. Modelling the cost effectiveness of antidepressant treatment in primary care.
Revicki DA; Brown RE; Palmer W; Bakish D; Rosser WW; Anton SF; Feeny D
Pharmacoeconomics; 1995 Dec; 8(6):524-40. PubMed ID: 10160081
[TBL] [Abstract][Full Text] [Related]
13. Mindfulness-based cognitive therapy for patients with medically unexplained symptoms: a cost-effectiveness study.
van Ravesteijn H; Grutters J; olde Hartman T; Lucassen P; Bor H; van Weel C; van der Wilt GJ; Speckens A
J Psychosom Res; 2013 Mar; 74(3):197-205. PubMed ID: 23438709
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis.
Manning VL; Kaambwa B; Ratcliffe J; Scott DL; Choy E; Hurley MV; Bearne LM
Rheumatology (Oxford); 2015 Feb; 54(2):302-9. PubMed ID: 25173349
[TBL] [Abstract][Full Text] [Related]
15. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
Kobelt G; Andlin-Sobocki P; Brophy S; Jönsson L; Calin A; Braun J
Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514
[TBL] [Abstract][Full Text] [Related]
16. Economic Evaluation of Concise Cognitive Behavioural Therapy and/or Pharmacotherapy for Depressive and Anxiety Disorders.
Meuldijk D; Carlier IV; van Vliet IM; van Hemert AM; Zitman FG; van den Akker-van Marle ME
J Ment Health Policy Econ; 2015 Dec; 18(4):175-83. PubMed ID: 26729009
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT Trial.
Hollinghurst S; Carroll FE; Abel A; Campbell J; Garland A; Jerrom B; Kessler D; Kuyken W; Morrison J; Ridgway N; Thomas L; Turner K; Williams C; Peters TJ; Lewis G; Wiles N
Br J Psychiatry; 2014 Jan; 204(1):69-76. PubMed ID: 24262818
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial.
Henderson C; Knapp M; Fernández JL; Beecham J; Hirani SP; Cartwright M; Rixon L; Beynon M; Rogers A; Bower P; Doll H; Fitzpatrick R; Steventon A; Bardsley M; Hendy J; Newman SP;
BMJ; 2013 Mar; 346():f1035. PubMed ID: 23520339
[TBL] [Abstract][Full Text] [Related]
19. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of improving primary care treatment of late-life depression.
Katon WJ; Schoenbaum M; Fan MY; Callahan CM; Williams J; Hunkeler E; Harpole L; Zhou XH; Langston C; Unützer J
Arch Gen Psychiatry; 2005 Dec; 62(12):1313-20. PubMed ID: 16330719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
